Pittsburgh, Pennsylvania
CNS clinical trials in Pittsburgh, PA
56 CNS studies are recruiting participants at sites in Pittsburgh as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Pittsburgh at a glance
- 56 studies are recruiting at a site in Pittsburgh.
- By phase: Phase 1 (2), Phase 1/2 (6), Phase 2 (1), Phase 3 (7), Phase 4 (2), No phase (29), Observational (9). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (40), industry (13), government (3).
- By research area: Depression (24), Parkinson's Disease (11), Schizophrenia (6), ADHD (5), Multiple Sclerosis (4), Epilepsy (3), Migraine (2), Bipolar Disorder (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Pittsburgh
Basic details from each study's public record (the 30 most recently updated of 56). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- UPMC Hillman Cancer Center · UPMC-Magee Womens Hospital · UPMC-Saint Margaret
- Registry record
- NCT06748222 · updated
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- No phase
- Ages 60 and older
- All sexes
- Sponsor
- University of Pittsburgh
- Study site
- University of Pittsburgh (UPMC)
- Registry record
- NCT06191484 · updated
Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments
- No phase
- Ages 18 to 55
- All sexes
- Sponsor
- Marta Peciña, MD PhD
- Study site
- Bellefield Towers
- Registry record
- NCT06976840 · updated
Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms
- No phase
- Ages 18 to 25
- All sexes
- Sponsor
- Michelle Stepan
- Study site
- University of Pittsburgh
- Registry record
- NCT05802004 · updated
An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Pittsburgh
- Study site
- University of Pittsburgh
- Registry record
- NCT07373470 · updated
Sleep Promotion Program Primary Care
- No phase
- Ages 12 to 18
- All sexes
- Sponsor
- University of Pittsburgh
- Study site
- University of Pittsburgh
- Registry record
- NCT06240325 · updated
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Pittsburgh
- Study site
- University of Pittsburgh
- Registry record
- NCT06978127 · updated
A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
- No phase
- Ages 13 to 24
- All sexes
- Sponsor
- Ksana Health
- Study sites
- STAR Center, Western Psychiatric Institute & Clinic · University of Pittsburgh
- Registry record
- NCT07348666 · updated
Apimostinel + Automated Neurocognitive Training for Depression
- Phase 2
- Ages 18 to 60
- All sexes
- Sponsor
- Rebecca Price
- Study site
- Western Psychiatric Institute and Clinic
- Registry record
- NCT06400121 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Schizophrenia studies recruiting in Pittsburgh
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
- No phase
- Ages 18 to 70
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
- Registry record
- NCT05157620 · updated
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
- No phase
- Ages 18 to 40
- All sexes
- Sponsor
- Fabio Ferrarelli
- Study site
- University of Pittsburgh
- Registry record
- NCT05102929 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Pittsburgh
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- No phase
- Ages 18 to 40
- All sexes
- Sponsor
- University of Pittsburgh
- Study site
- University of Pittsburgh Medical Center
- Registry record
- NCT06081426 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
ADHD studies recruiting in Pittsburgh
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- University of Pittsburgh Medical Center
- Registry record
- NCT03047369 · updated
AWARE: Management of ADHD in Autism Spectrum Disorder
- Phase 4
- Ages 4 to 17
- All sexes
- Sponsor
- Daniel Coury
- Study site
- University of Pittsburgh
- Registry record
- NCT05916339 · updated
Smartphone-based Intervention for Young Adults With ADHD
- No phase
- Ages 18 to 25
- All sexes
- Sponsor
- Traci Kennedy
- Study site
- University of Pittsburgh
- Registry record
- NCT07654205 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Pittsburgh
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UPMC Hillman Cancer Center-UPMC ( Site 6904)
- Registry record
- NCT06469944 · updated
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Observational
- All ages
- All sexes
- Sponsor
- Boston Scientific Corporation
- Study site
- Allegheny General Hospital
- Registry record
- NCT03664609 · updated
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Jorge Gonzalez-Martinez
- Study site
- University of Pittsburgh
- Registry record
- NCT07056361 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- AHN West Penn Hospital ( Site 6006)
- Registry record
- NCT06952504 · updated
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Allegheny General Hospital
- Registry record
- NCT07174310 · updated
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UPMC Hillman Cancer Center-UPMC ( Site 4904)
- Registry record
- NCT05319730 · updated
Parkinson's Foundation PD GENEration Genetic Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Parkinson's Foundation
- Study site
- Allegheny Health Network
- Registry record
- NCT04994015 · updated
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- UPMC Hillman Cancer Center-UPMC ( Site 8904)
- Registry record
- NCT06445972 · updated
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Observational
- Ages 30 and older
- All sexes
- Sponsor
- Michael J. Fox Foundation for Parkinson's Research
- Study site
- University of Pittsburgh
- Registry record
- NCT04477785 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Pittsburgh
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UPMC Hillman Cancer Center
- Registry record
- NCT03816345 · updated
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- UniQure Biopharma B.V.
- Study site
- Allegheny Health Network
- Registry record
- NCT06063850 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Epilepsy studies recruiting in Pittsburgh
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- UPMC Comprehensive Epilepsy Center
- Registry record
- NCT05667142 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Migraine studies recruiting in Pittsburgh
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Preferred Primary Care Physicians, Inc.
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Preferred Primary Care Physicians, Inc.
- Registry record
- NCT07674654 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Pittsburgh, PA on ClinicalTrials.gov.
Ask about studies near Pittsburgh
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Pennsylvania
All Pennsylvania locations
162 studies recruiting across 42 cities.
Philadelphia
97 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections